ADC Therapeutics SA Quarterly Interest Expense in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
ADC Therapeutics SA quarterly/annual Interest Expense history and growth rate from Q1 2023 to Q3 2024.
  • ADC Therapeutics SA Interest Expense for the quarter ending September 30, 2024 was $13.1M, a 2.35% increase year-over-year.
  • ADC Therapeutics SA Interest Expense for the twelve months ending September 30, 2024 was $51.2M.
  • ADC Therapeutics SA annual Interest Expense for 2023 was $46.3M, a 26.1% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $51.2M $13.1M +$301K +2.35% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $50.9M $12.7M +$2.37M +23% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $48.5M $12.5M +$2.21M +21.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $46.3M $12.9M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $12.8M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $10.3M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $10.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.